[go: up one dir, main page]

WO2001077130A3 - Haplotypes du gene apoa2 - Google Patents

Haplotypes du gene apoa2 Download PDF

Info

Publication number
WO2001077130A3
WO2001077130A3 PCT/US2001/011854 US0111854W WO0177130A3 WO 2001077130 A3 WO2001077130 A3 WO 2001077130A3 US 0111854 W US0111854 W US 0111854W WO 0177130 A3 WO0177130 A3 WO 0177130A3
Authority
WO
WIPO (PCT)
Prior art keywords
apoa2
gene
haplotypes
disclosed
apoa2 gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/011854
Other languages
English (en)
Other versions
WO2001077130A2 (fr
Inventor
Anne Chew
Julie Y Choi
Beena Koshy
J Claiborne Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Priority to AU2001255318A priority Critical patent/AU2001255318A1/en
Publication of WO2001077130A2 publication Critical patent/WO2001077130A2/fr
Publication of WO2001077130A3 publication Critical patent/WO2001077130A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Medical Informatics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne de nouveaux polymorphismes mononucléotidiques dans le gène humain apolipoprotéine A-II (APOA2). En outre, elle porte sur divers génotypes, haplotypes et paires d'haplotype pour le gène APOA2 qui existent dans la population. Elle traite également de compositions et de procédés d'haplotypage et/ou de génotypage du gène APOA2 chez un individu. Elle concerne enfin des polynucléotides contenant au moins un polymorphisme APOA2.
PCT/US2001/011854 2000-04-11 2001-04-11 Haplotypes du gene apoa2 Ceased WO2001077130A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001255318A AU2001255318A1 (en) 2000-04-11 2001-04-11 Haplotypes of the apoa2 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19581700P 2000-04-11 2000-04-11
US60/195,817 2000-04-11

Publications (2)

Publication Number Publication Date
WO2001077130A2 WO2001077130A2 (fr) 2001-10-18
WO2001077130A3 true WO2001077130A3 (fr) 2002-03-21

Family

ID=22722935

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/011854 Ceased WO2001077130A2 (fr) 2000-04-11 2001-04-11 Haplotypes du gene apoa2

Country Status (2)

Country Link
AU (1) AU2001255318A1 (fr)
WO (1) WO2001077130A2 (fr)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LACKNER ET AL.: "The human apolipoproteins A-II gene: complete nucleic acid sequence and genomic organization", NUCLEIC ACIDS RESEARCH, vol. 13, no. 12, 1985, XP002947120 *

Also Published As

Publication number Publication date
WO2001077130A2 (fr) 2001-10-18
AU2001255318A1 (en) 2001-10-23

Similar Documents

Publication Publication Date Title
WO2001079234A3 (fr) Haplotypes du gene apoe
WO2001079229A3 (fr) Haplotypes du gene cxcr4
WO2001077124A3 (fr) Haplotypes du gene apoa4
WO2001090123A3 (fr) Haplotypes du gene agtrl1
WO2001079230A3 (fr) Haplotypes du gene ugt1a1
WO2001079228A3 (fr) Haplotypes du gene f12
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2001077130A3 (fr) Haplotypes du gene apoa2
WO2001077363A3 (fr) Haplotypes du gene impdh2
WO2001077129A3 (fr) Haplotypes du gene apoc1
WO2001077127A3 (fr) Haplotypes du gene apoc4
WO2001079218A3 (fr) Haplotypes du gene calm1
WO2001077131A3 (fr) Haplotypes du gene bglap
WO2001079219A3 (fr) Haplotypes du gene ache
WO2001072966A3 (fr) Haplotypes du gene pltp
WO2001079240A3 (fr) Haplotypes du gene rangap1
WO2001079974A3 (fr) Haplotypes du gene f9
WO2001090127A3 (fr) Haplotypes du gene de hoxd3
WO2001079232A3 (fr) Haplotypes du gene mpl
WO2001090120A3 (fr) Haplotypes du gene evx1
WO2001075065A3 (fr) Haplotypes du gene gp1ba
WO2001072965A3 (fr) Haplotypes du gene fkbp8
WO2001079237A3 (fr) Haplotypes du gene galr1
WO2001079238A3 (fr) Haplotypes du gene mmp3
WO2001075063A3 (fr) Haplotypes du gene chrnb3

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP